The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Clinical trial NCT04329728 · RECRUITING

Trial details

NCT number: NCT04329728
Sponsor: AVM Biotechnology Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoid Malignancies

Start date: 2020-11-06
Primary completion: 2027-11-30
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.